Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

A new type of alopecia areata, called the "confetti variant," causes small bald spots that often heal on their own in a few months.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

88% phenol is effective for treating alopecia areata.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Hair loss in alopecia areata can negatively affect sexual quality of life.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

Some drugs can cause permanent hair loss, though it's rare.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Some drugs used to treat immune conditions may cause different types of hair loss.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Manipulating cell cleanup processes could help treat hair loss.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Atopic dermatitis increases the risk of some autoimmune diseases.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.